Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Starch Medical
San Jose, California, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Starch Medical's AMP-based hemostatic device products—including SealFoam, RESPONDER, SuperClot, and PerClot—are commercially available and used as adjuncts to control bleeding in surgical and trauma settings, with global regulatory approvals and expanding IP portfolio.
- Therapeutic areas
- Hematology
- Modalities
- Device
- Industry
- Surgical Medical Devices
Beyond the preview
Go deeper on Starch Medical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Starch Medical.